Vivani Competitors
| VANI Stock | USD 1.26 0.03 2.33% |
Vivani Medical vs ImageneBio Correlation
Very weak diversification
The correlation between Vivani Medical and IMA is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vivani Medical and IMA in the same portfolio, assuming nothing else is changed.
Moving against Vivani Stock
The current Return On Tangible Assets is estimated to decrease to -0.53. The current Return On Capital Employed is estimated to decrease to -0.66. As of now, Vivani Medical's Debt To Assets are decreasing as compared to previous years. The Vivani Medical's current Asset Turnover is estimated to increase to 0.23, while Total Assets are projected to decrease to under 25.4 M.Vivani Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vivani Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Vivani and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vivani Medical does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Vivani Stock performing well and Vivani Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vivani Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NSPR | 3.30 | (0.30) | 0.00 | (0.11) | 0.00 | 6.53 | 24.29 | |||
| HYPR | 4.01 | (0.05) | (0.01) | 0.04 | 4.14 | 9.09 | 18.91 | |||
| RCEL | 2.50 | 0.22 | 0.06 | 0.80 | 2.39 | 6.67 | 17.83 | |||
| MBOT | 3.54 | (0.14) | (0.01) | 0.02 | 3.77 | 8.64 | 30.11 | |||
| QIPT | 1.75 | 0.76 | 0.47 | (3.19) | 0.32 | 3.88 | 34.66 | |||
| FONR | 1.23 | 0.40 | 0.32 | 309.39 | 0.45 | 1.96 | 27.36 | |||
| EDAP | 4.30 | 1.21 | 0.30 | 0.69 | 3.52 | 14.48 | 38.43 | |||
| ORMP | 2.76 | 0.61 | 0.26 | 0.37 | 1.98 | 6.98 | 17.67 | |||
| CRDL | 2.50 | 0.09 | 0.00 | (0.27) | 3.01 | 7.07 | 15.37 | |||
| IMA | 2.61 | (0.15) | 0.00 | (0.38) | 0.00 | 6.76 | 18.29 |
Cross Equities Net Income Analysis
Compare Vivani Medical and related stocks such as InspireMD, Hyperfine, and Avita Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NSPR | (3.8 K) | (17.6 M) | (17.6 M) | (29.3 M) | (25.1 M) | (15.6 M) | (8.5 M) | (8.4 M) | (7.2 M) | (10 M) | (10.5 M) | (14.9 M) | (18.5 M) | (19.9 M) | (32 M) | (28.8 M) | (27.4 M) |
| HYPR | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (23.4 M) | (64.8 M) | (73.2 M) | (44.2 M) | (40.7 M) | (36.6 M) | (38.5 M) |
| RCEL | (225.5 K) | (7.6 M) | (8.1 M) | (5.1 M) | (7.9 M) | (10.3 M) | (11.5 M) | (17.2 M) | (24.6 M) | (24.6 M) | (24.6 M) | (25.1 M) | (26.7 M) | (35.4 M) | (61.8 M) | (55.7 M) | (52.9 M) |
| MBOT | (6.4 M) | (21.3 M) | (28.5 M) | (26.4 M) | (32.7 M) | (36.4 M) | (9.7 M) | (7.6 M) | (7.3 M) | (7.2 M) | (9.2 M) | (11.3 M) | (13.2 M) | (10.7 M) | (11.4 M) | (10.3 M) | (10.8 M) |
| QIPT | (34.1 K) | (548 K) | (2.5 M) | (1.4 M) | (18.3 M) | (57.4 M) | (19.2 M) | 14.5 M | (5.6 M) | (4.6 M) | (6.2 M) | 4.8 M | (2.8 M) | (6.8 M) | (10.7 M) | (9.6 M) | (9.1 M) |
| FONR | (7.5 M) | 5.8 M | 8.7 M | 10.4 M | 12.9 M | 15.7 M | 19.6 M | 21.2 M | 15.3 M | 8.2 M | 10.2 M | 12.4 M | 9.4 M | 10.6 M | 8.3 M | 9.6 M | 10.1 M |
| EDAP | 181.8 K | (938 K) | (7.5 M) | (5 M) | (512 K) | (1.7 M) | 3.8 M | (681 K) | (338 K) | 1.5 M | (1.7 M) | 700 K | (2.9 M) | (21.2 M) | (19 M) | (17.1 M) | (16.3 M) |
| ORMP | (50 K) | (1.6 M) | (3.3 M) | (4.2 M) | (5.7 M) | (7.2 M) | (11 M) | (10.5 M) | (12.7 M) | (14.4 M) | (11.5 M) | (22.2 M) | (37.8 M) | 5.5 M | (19.1 M) | (17.2 M) | (16.3 M) |
| CRDL | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (15.9 M) | (10.6 M) | (16.2 M) | (25 M) | (22.8 M) | (21.2 M) | (36.7 M) | (33 M) | (31.4 M) |
| IMA | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (40.9 M) | (16.8 M) | (44.3 M) | (34.1 M) | (68.8 M) | (68.2 M) | (36.6 M) | (32.9 M) | (34.6 M) |
Vivani Medical and related stocks such as InspireMD, Hyperfine, and Avita Medical Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Vivani Medical financial statement analysis. It represents the amount of money remaining after all of Vivani Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Vivani Medical Competitive Analysis
The better you understand Vivani Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vivani Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vivani Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Vivani Medical Competition Performance Charts
Five steps to successful analysis of Vivani Medical Competition
Vivani Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Vivani Medical in relation to its competition. Vivani Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Vivani Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Vivani Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Vivani Medical, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Vivani Medical position
In addition to having Vivani Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Vivani Medical Correlation with its peers. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is there potential for Biotechnology market expansion? Will Vivani introduce new products? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Vivani Medical requires distinguishing between market price and book value, where the latter reflects Vivani's accounting equity. The concept of intrinsic value - what Vivani Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Vivani Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vivani Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.